PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drug combination treats hepatitis C patients also infected with HIV

Novel treatment has 97 percent success rate in co-infected patients

2015-07-22
(Press-News.org) Roughly 20 to 30 percent of patients with hepatitis C virus (HCV) are also infected with human immunodeficiency virus type 1 (HIV). Both blood-borne viruses share the same modes of transmission, but many HCV medications currently have significant limitations due to adverse interactions with HIV treatments. Researchers at University of California, San Diego School of Medicine report a new combination that effectively treats HCV in patients co-infected with HIV.

The study, published online in the New England Journal of Medicine, found the combination of HCV drugs daclatasvir and sofosbuvir - both pills - cured HCV in 97 percent of patients also infected with HIV.

"In many HCV/HIV co-infected patients, HCV therapies can have a strong interaction with HIV medications that complicate or potentially exclude them from HCV treatment," said David Wyles, MD, lead author of the study in the Division of Infectious Diseases. "This study is novel because it shows the new drug combination was not compromised when used with a wide range of HIV medications, increasing the number of HCV/HIV patients who can be treated without modifying their HIV medications."

The 12-week study involved 151 patients and was the first to test this treatment regimen in those with HIV/HCV. Patients who participated in the clinical trial were closely monitored up to 24 weeks post treatment.

Another reason the study findings are important, said Wyles, is because HCV is a major cause of chronic liver disease in the United States, and liver damage progresses more rapidly in those also infected with HIV.

"Liver disease is a leading cause of death among HIV patients, so it is a high priority to treat co-infected patients and reduce the potentially fatal effect," said Wyles, also associate professor of medicine at UC San Diego School of Medicine.

Sofosbuvir is already approved for use in the United States; daclatasvir is scheduled to be reviewed by the Food and Drug Administration in August.

"These findings are very exciting in the infectious diseases world, as they could help an entire demographic that has historically struggled finally receive successful treatment for HCV," said Wyles.

INFORMATION:

Co-authors include Peter J. Ruane, MD, Ruane Medical and Liver Health Institute; Mark S. Sulkowski, MD, Johns Hopkins University, Lutherville, MD; Douglas Dieterich, MD, Icahn School of Medicine at Mount Sinai, New York; Anne Luetkemeyer, MD, Los Angeles, the University of California, San Francisco, San Francisco; Timothy R. Morgan, MD, Veterans Affairs Long Beach Healthcare System, Long Beach; Kenneth E. Sherman, MD, PhD, University of Cincinnati College of Medicine, Cincinnati; Robin Dretler, MD, Infectious Disease Specialists of Atlanta, Decatur, GA; Dawn Fishbein, MD, MedStar Washington Hospital Center; Joseph C. Gathe, Jr., MD, the Cure C Consortium, Houston; Sarah Henn, MD, Whitman-Walker Health; Federico Hinestrosa, MD, Orlando Immunology Center, Orlando; Charles Huynh, DO, the Jeffrey Goodman Clinic, Los Angeles LGBT Center; Cheryl McDonald, MD, Tarrant County Infectious Disease Associates, Fort Worth; Anthony Mills, MD, Southern California Men's Medical Group-Men's Health Foundation; Edgar Turner Overton, MD, the University of Alabama at Birmingham, Birmingham; Moti Ramgopal, MD, Midway Immunology and Research Center, Fort Pierce; Bruce Rashbaum, MD, Capital Medical Associates; Graham Ray, MSN, ANP, the University of Colorado, Denver; Anthony Scarsella, MD, Pacific Oaks Medical Group, Beverly Hills; Joseph Yozviak, DO, Lehigh Valley Health Network, Allentown, PA; Fiona McPhee, PhD, Philip D. Yin, MD, PhD, Peter Ackerman, MD - all with Bristol-Myers Squibb, Wallingford, CT; Eric Hughes, MD, PhD, Stephanie Noviello, MD Zhaohui Liu, PhD - all with Princeton, NJ.

Funding for this research came, in part, from Bristol Myers Squibb.



ELSE PRESS RELEASES FROM THIS DATE:

Low-nicotine cigarettes fail to sway smokers

2015-07-22
Smokers who successfully lowered their nicotine intake when they were switched to low-nicotine cigarettes were unable to curb their smoking habits in the long term, according to a study by researchers at UCSF and San Francisco General Hospital and Trauma Center. The study, published online today (July 22) in the journal Addiction found that levels of cotinine, a derivative of nicotine measured in the blood, plummeted six months after smokers' regular cigarettes were replaced with low-nicotine ones. But levels started to rebound later into the study when smokers returned ...

Hair ice mystery solved

Hair ice mystery solved
2015-07-22
You may have never seen or heard of it, but hair ice - a type of ice that has the shape of fine, silky hairs and resembles white candy floss - is remarkable. It grows on the rotten branches of certain trees when the weather conditions are just right, usually during humid winter nights when the air temperature drops slightly below 0°C. Now, a team of scientists in Germany and Switzerland have identified the missing ingredient that gives hair ice its peculiar shape: the fungus Exidiopsis effusa. The research is published today (22 July) in Biogeosciences, an open access ...

Having wealthy neighbors may skew beliefs about overall wealth distribution

2015-07-22
Wealthy people may be likely to oppose redistribution of wealth because they have biased information about how wealthy most people actually are, according to new research published in Psychological Science, a journal of the Association for Psychological Science. The findings indicate that people use their own neighborhoods and communities as a gauge of how much wealth other people possess, leading wealthy people to perceive the broader population as being wealthier than it actually is. "If you're rich, there's a good chance you know lots of other rich people and relatively ...

Current dietary protein recommendations need updating

2015-07-22
New research based on modern techniques suggests that recommendations for protein intake in healthy populations may be incorrect. In a paper just published in Applied Physiology, Nutrition, and Metabolism, an NRC Research Press journal (a division of Canadian Science Publishing), researchers put the focus on protein as an essential component of a healthy diet. Protein helps people stay full longer, preserve muscle mass, and when combined with adequate physical activity, has the potential to serve as a key nutrient for important health outcomes and benefits. It's not ...

New evidence of cultural diversification between neighboring chimpanzee communities

New evidence of cultural diversification between neighboring chimpanzee communities
2015-07-22
For centuries it has been thought that culture is what distinguishes humans from other animals, but over the past decade this idea has been repeatedly called into question. Cultural variation has been identified in a growing number of species in recent years, ranging from primates to cetaceans. Chimpanzees, our closest living relatives, show the most diverse cultures aside from humans, most notably, in their use of a wide variety of tools. The method traditionally used to establish the presence of culture in wild animals compares behavioural variation across populations ...

A dictionary of the language of cells

2015-07-22
In their struggle to survive and prosper, multicellular organisms rely on a complex network of communication between cells, which in humans are believed to number about 40 trillion. Now, in a study published in Nature Communications, a research group led by scientists from the RIKEN Center for Life Science Technologies (CLST) has published an overall map of how the cells in the human body communicate by systematically analyzing the relationship between ligands--substances such as insulin and interferon that embody messages between cells, and receptors--the proteins on cell ...

Targeting the strain of bacteria that causes ulcers may help prevent stomach cancer

2015-07-22
A new review published in the Cochrane Library, indicates that eradicating Helicobacter pylori bacterium-- the main cause of stomach ulcers - with a short course of therapy comprising two commonly used medicines may help to reduce the risk of gastric cancer. Stomach, or gastric, cancer is the third most common cause of death from cancer worldwide, and people who are infected with the Helicobacter pylori bacterium are more likely to develop the disease. About two-thirds of us have H. pylori in our bodies, but in most cases we experience no discomfort or other symptoms. ...

Progressively reducing the nicotine content of cigarettes may not lead smokers to quit

2015-07-22
The US Family Smoking Prevention and Tobacco Control Act, passed in 2009, permits the U.S. Food and Drug Administration (FDA) to set standards for cigarette nicotine content. The FDA is accordingly supporting research into how very low nicotine content (VLNC) cigarettes might function as a regulatory measure to make cigarettes non-addictive, reduce smoke exposure, and improve public health, even among people who don't want to quit smoking. New research published today in the scientific journal Addiction shows that simply reducing the nicotine content of cigarettes may ...

HIV treatment has social and socioeconomic benefits, as well as improved health: Study

2015-07-22
New research shows that HIV treatment for illicit drug users improves their social and socioeconomic wellbeing as well as their health. While the health benefits of antiretroviral therapy (ART) for HIV are well documented, less is known about possible secondary benefits. Lindsey Richardson, an assistant professor in the Department of Sociology at the University of British Columbia and research scientist with the BC Centre for Excellence in HIV/AIDS (BC-CfE), presented findings from two studies July 22 at the International AIDS Society (IAS) Conference in Vancouver. ...

Selfishness lasts a lifetime, according to mongoose study

Selfishness lasts a lifetime, according to mongoose study
2015-07-22
Researchers studying wild banded mongooses in Uganda have discovered that these small mammals have either cooperative or selfish personalities which last for their entire lifetime. The findings of the 15-year study are published today in the journal Animal Behaviour. The researchers investigated the selfish behaviour of mongoose mate-guarding - where dominant males guard particular females - and the cooperative behaviour of 'babysitting' and 'escorting' the young. They found that cooperative mongooses that helped out with offspring care did so consistently over their ...

LAST 30 PRESS RELEASES:

Keeping pediatrics afloat in a sea of funding cuts

Giant resistivity reduction in thin film a key step towards next-gen electronics for AI

First pregnancy with AI-guided sperm recovery method developed at Columbia

Global study reveals how bacteria shape the health of lakes and reservoirs

Biochar reimagined: Scientists unlock record-breaking strength in wood-derived carbon

Synthesis of seven quebracho indole alkaloids using "antenna ligands" in 7-10 steps, including three first-ever asymmetric syntheses

BioOne and Max Planck Society sign 3-year agreement to include subscribe to open pilot

How the arts and science can jointly protect nature

Student's unexpected rise as a researcher leads to critical new insights into HPV

Ominous false alarm in the kidney

MSK Research Highlights, October 31, 2025

Lisbon to host world’s largest conference on ecosystem restoration in 2027, led by researcher from the Faculty of Sciences, University of Lisbon

Electrocatalysis with dual functionality – an overview

Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection

New post-hoc analysis shows patients whose clinicians had access to GeneSight results for depression treatment are more likely to feel better sooner

First transplant in pigs of modified porcine kidneys with human renal organoids

Reinforcement learning and blockchain: new strategies to secure the Internet of Medical Things

Autograph: A higher-accuracy and faster framework for compute-intensive programs

Expansion microscopy helps chart the planktonic universe

Small bat hunts like lions – only better

As Medicaid work requirements loom, U-M study finds links between coverage, better health and higher employment

Manifestations of structural racism and inequities in cardiovascular health across US neighborhoods

Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity

Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes

Bimodal tactile tomography with bayesian sequential palpation for intracavitary microstructure profiling and segmentation

IEEE study reviews novel photonics breakthroughs of 2024

New method for intentional control of bionic prostheses

Obesity treatment risks becoming a ‘two-tier system’, researchers warn

Researchers discuss gaps, obstacles and solutions for contraception

Disrupted connectivity of the brainstem ascending reticular activating system nuclei-left parahippocampal gyrus could reveal mechanisms of delirium following basal ganglia intracerebral hemorrhage

[Press-News.org] New drug combination treats hepatitis C patients also infected with HIV
Novel treatment has 97 percent success rate in co-infected patients